AIDS 2003: A Year in ReviewAUTRAN, Brigitte; COUNTINHO, Roel; LEVY, Jay et al.AIDS (Supplement). 2003, Vol 17, issn 1350-2840, 133 p., SUP4Serial Issue

New antiretroviral drugs and approaches to HIV treatmentPAREDES, Roger; CLOTET, Bonaventura.AIDS (Supplement). 2003, Vol 17, pp S85-S96, issn 1350-2840, SUP4Article

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication, by Martínez et alCROWE, Suzanne.AIDS (Supplement). 2003, Vol 17, pp S103-SS105, issn 1350-2840, SUP4Article

Treatment of tuberculosis in HIV infected persons in the era of highly active antiretroviral therapy, by Dean et alWANKE, Christine.AIDS (Supplement). 2003, Vol 17, pp S112-S114, issn 1350-2840, SUP4Article

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients, by Ghosn et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S117-S119, issn 1350-2840, SUP4Article

Virus-host interactions: role of HIV proteins vif, tat, and revSTREBEL, Klaus.AIDS (Supplement). 2003, Vol 17, pp S25-S34, issn 1350-2840, SUP4Article

Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants, by Dowling et alHOGG, Robert S.AIDS (Supplement). 2003, Vol 17, pp S125-S127, issn 1350-2840, SUP4Article

Effect of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial), by Ling et alCROWE, Suzanne.AIDS (Supplement). 2003, Vol 17, pp S105-S107, issn 1350-2840, SUP4Article

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG study A5047, by Fichtenbaum et alWANKE, Christine.AIDS (Supplement). 2003, Vol 17, pp S109-S110, issn 1350-2840, SUP4Article

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S114-S116, issn 1350-2840, SUP4Article

Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa, by Gregson et alMASTRO, Timothy D.AIDS (Supplement). 2003, Vol 17, pp S122-S123, issn 1350-2840, SUP4Article

Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection, by Mulherin et alHOGG, Robert S.AIDS (Supplement). 2003, Vol 17, pp S127-S128, issn 1350-2840, SUP4Article

B cell activation in peripheral blood and lymph nodes during HIV infection, by Zamarchi et alCLERICI, Mario.AIDS (Supplement). 2003, Vol 17, pp S99-S101, issn 1350-2840, SUP4Article

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S116-S117, issn 1350-2840, SUP4Article

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up, by Hogg et alMASTRO, Timothy D.AIDS (Supplement). 2003, Vol 17, pp S123-S124, issn 1350-2840, SUP4Article

Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania Pujades, by Rodríguez et alHOGG, Robert S.AIDS (Supplement). 2003, Vol 17, pp S128-S130, issn 1350-2840, SUP4Article

Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques, by Rasmussen et alCLERICI, Mario.AIDS (Supplement). 2003, Vol 17, pp S97-S99, issn 1350-2840, SUP4Article

Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy, by McComsey et alCLERICI, Mario.AIDS (Supplement). 2003, Vol 17, pp S101-S103, issn 1350-2840, SUP4Article

SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans, by Stellbrink et alCROWE, Suzanne.AIDS (Supplement). 2003, Vol 17, pp S107-S108, issn 1350-2840, SUP4Article

Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels, by Simpson et alWANKE, Christine.AIDS (Supplement). 2003, Vol 17, pp S111-S112, issn 1350-2840, SUP4Article

Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Côte d'Ivoire, 1991-1998, by Ghys et alMASTRO, Timothy D.AIDS (Supplement). 2003, Vol 17, pp S121-S122, issn 1350-2840, SUP4Article

CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivoBHATTACHARYA, Jayanta; PETERS, Paul J; CLAPHAM, Paul R et al.AIDS (Supplement). 2003, Vol 17, pp S35-S43, issn 1350-2840, SUP4Article

Growing in silence: selected regions and countries with expanding HIV/AIDS epidemicsGHYS, Peter D; SAIDEL, Tobi; HOANG TRAN VU et al.AIDS (Supplement). 2003, Vol 17, pp S45-S50, issn 1350-2840, SUP4Article

The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapyJIANMING TANG; KASLOW, Richard A.AIDS (Supplement). 2003, Vol 17, pp S51-S60, issn 1350-2840, SUP4Article

Present status of human HIV vaccine developmentCALAROTA, Sandra A; WEINER, David B.AIDS (Supplement). 2003, Vol 17, pp S73-S84, issn 1350-2840, SUP4Article